As killing capacity and cytokine production of CD8+ T cells is pivotal for their function in anti-tumor immunity, we further analyzed CD8+ T cell functionality on degranulation and polyfunctional effector cytokine production after one week of rechallenge in absence of AKT-inhibitors. The gene discussed is CD8A; the disease is neoplasm.